Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New university course designed for business minds interested in the biosciences
  • USA - English


News provided by

Birkbeck, University of London

Dec 09, 2013, 19:00 ET

Share this article

Share toX

Share this article

Share toX

Birkbeck's main building in Bloomsbury, central London
Birkbeck's main building in Bloomsbury, central London

(PRWEB UK) 10 December 2013 -- A new postgraduate degree at Birkbeck, University of London, will provide students with the business skills to launch, or further, their enterprises in the biosciences.

The MSc in Bio-business has been developed to attract business minded and entrepreneurial people eager to work in the biological and chemical sciences – growing industries within the UK economy. According to the Department for Business, Innovation and Skills, manufacturing in the life sciences accounts for eight per cent of the UK’s manufacturing and remains important for the UK’s growth.

This new programme combines learning about the biosciences and business in a unique way. It will benefit students embarking on careers in the biosciences and it will boost the sector as a whole by developing the next generation of talented individuals.

Post this

Staff will promote the course at the Genesis 2013 conference – London’s premier life science and healthcare networking conference – on 12 December at the Queen Elizabeth II Conference Centre. The new course will start in September 2014.

The content of the course is tailored to the unique demands of science-based projects, including the pharmaceutical and biotechnology sectors. A combination of scientific and entrepreneurial modules will enable students to move between scientific and business careers.

The course is a pioneering partnership between Birkbeck’s Department of Biological Sciences and its Department of Management. Students will learn about management and business principles, and research methods, from staff at Birkbeck’s Centre for Innovation Management Research (CIMR) in the Department of Management, and the Department of Biological Sciences.

The MSc in Bio-business will provide students with a thorough understanding of:
• The importance of innovation, research and technology in business strategy
• The role of risk management, regulation, public perception and media coverage
• The types of technologies and outputs used in biological and chemical science industries
• Historical and forward-looking perspectives about the biological and chemical science industries.

Dr Renos Savva, course organiser and Senior Research Fellow in Structural Molecular Biology at Birkbeck’s Department of Biological Sciences, will be leading the two biological science modules. He said: “This new programme combines learning about the biosciences and business in a unique way. It will benefit students embarking on careers in the biosciences and it will boost the sector as a whole by developing the next generation of talented individuals.”

Andrew Atter, Entrepreneur-in-Residence at Birkbeck’s School of Business, Economics and Informatics, will be leading the entrepreneurial module. He said: “Entrepreneurship in the bioscience and pharmaceutical industries is an increasingly important topic in public policy and is growing in significance to the UK economy. It is recognised that the transition from research science project into a viable business is fraught with difficulty and risk, so this MSc in Bio-business will make a valuable contribution to overcoming these problems.”

For more information and to register your interest for the MSc in Bio-business, visit: http://www.bbk.ac.uk/MScBio-Business. Applications will open in January 2014.

Notes to editors
• To interview Dr Renos Savva or Andrew Atter, please contact Guy Collender (g.collender(at)bbk(dot)ac.uk , 020 7380 3108).
• For more information about the course, visit Birkbeck’s stand at the Genesis 2013 conference (visit http://www.genesisconference.com ) at the Queen Elizabeth II Conference Centre on 12 December, or speak to staff at Birkbeck’s Open Evenings (visit http://www.bbk.ac.uk/openeve).
• The fees for the course are as follows:
-Part-time two-year course, home/EU students: £ 4975 pa
-Full-time one-year course, home/EU students: £ 9950 pa
-Part-time two-year course, overseas students: £ 7425 pa
-Full-time one-year course, overseas students: £ 14775 pa
• According to the Department for Business, Innovation and Skills, the pharmaceuticals sector alone accounts for more than 28 per cent of all business research and development in the UK, more than any other manufacturing sector.
• Birkbeck is a world-class research and teaching institution, a vibrant centre of academic excellence and London’s only specialist provider of evening higher education.
• 18,000 students study at Birkbeck every year. They join a community that is as diverse and cosmopolitan as London’s population.
• Birkbeck welcomes applications from non-traditional students and is committed to widening access to higher education.
• This autumn Birkbeck opened its £33m state-of-the-art campus, called University Square Stratford, in east London as part of a collaboration between Birkbeck and the University of East London.
• For more information about Birkbeck contact Guy Collender (g.collender(at)bbk(dot)ac.uk , 020 7380 3108).

Guy Collender, Birkbeck, University of London, http://www.bbk.ac.uk, +44 2073803108 Ext: 3108, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.